White House Drug Strategy Targets High-THC Products, Cartel Activity

The Biden administration's 2025 National Drug Control Strategy singles out high-potency cannabis products and their marketing practices as emerging threats, while warning that organized crime groups are taking advantage of state legalization frameworks.

The document, released Monday by the White House Office of National Drug Control Policy, dedicates multiple sections to cannabis concerns despite ongoing federal rescheduling efforts. It specifically highlights products with THC concentrations above 15% and marketing tactics that allegedly target youth.

"We are seeing international cartels and criminal organizations exploit gaps in state regulatory systems," according to the strategy document. The policy paper stops short of calling for federal intervention in state markets but emphasizes coordination between federal and state law enforcement.

The Hemp THC Crackdown

The strategy arrives as the cannabis industry braces for major regulatory changes to hemp-derived products. Under provisions in the 2023 Farm Bill reauthorization, products containing synthesized or converted THC from hemp will become federally prohibited starting later this year.

That ban will affect a market segment worth an estimated $2 billion annually, including delta-8 THC products sold in gas stations and convenience stores nationwide. The White House document frames these products as particularly problematic, citing their availability outside regulated state systems.

"The hemp loophole has created a largely unregulated market," said Jonathan Miller, general counsel for the U.S. Hemp Roundtable, in recent testimony to Congress. "But the solution should distinguish between legitimate hemp businesses and bad actors."

Industry Pushback on Potency Claims

Cannabis industry groups quickly challenged the strategy's focus on high-potency products. The National Cannabis Industry Association pointed out that state-regulated markets already impose testing requirements and potency limits in many jurisdictions.

Colorado limits concentrates to 90% THC for recreational sales. Washington state requires warning labels on products above 20% THC. California mandates child-resistant packaging and restricts serving sizes for edibles to 10mg THC.

"Regulated markets provide consumer protections that prohibition never could," said Aaron Smith, co-founder of the National Cannabis Roundtable. "The answer to concerns about potency is more regulation, not less legalization."

The strategy document acknowledges state regulatory efforts but suggests federal oversight may be necessary. It calls for increased research into high-potency products' health effects and their connection to cannabis use disorder.

What This Means for Rescheduling

The timing raises questions about the administration's commitment to moving cannabis to Schedule III of the Controlled Substances Act. That rescheduling process, initiated by President Biden in 2022, remains under review at the Drug Enforcement Administration.

"You can't simultaneously call for rescheduling while demonizing legal state markets," said Paul Armentano, deputy director of NORML. "The mixed messaging creates uncertainty for businesses operating in good faith."

The Justice Department has indicated it will issue a final rule on rescheduling in 2025, though no specific timeline has been announced. The DEA received more than 43,000 public comments during its review period, the majority supporting the Schedule III designation.

The Cartel Question

The strategy's focus on cartel involvement in state markets echoes arguments made by legalization opponents. However, recent federal enforcement actions have targeted illegal grows operating outside state licensing systems, not licensed businesses.

Last year, federal and state authorities shut down 170 unlicensed cultivation operations in Oklahoma alone. Similar enforcement swept through California's Central Valley and rural Oregon counties.

"The problem isn't legalization—it's insufficient resources for state regulators," said Chelsea Boyd, policy manager at the Parachute nonprofit. "States need federal support to strengthen licensing and enforcement, not rhetoric that undermines legal markets."

The White House strategy proposes $40.1 billion in drug control funding for fiscal year 2026, but doesn't specify how much would go toward cannabis-related enforcement versus treatment and prevention programs.

---

This article is based on original reporting by www.marijuanamoment.net.